جست‌وجوی استاد و پژوهشگر

• Epigenetics
• Retroelements
• Transposable elements
• +۵ مورد دیگر

Didier Trono is a Full Professor at École Polytechnique Fédérale de Lausanne (EPFL), where he leads the Laboratory of Virology and Genetics (LVG) within the School of Life Sciences. Formerly, from 2004 to 2012, he served as the founding dean of EPFL's Faculty of Life Sciences, orchestrating its development and growth during this formative period. Trono received his medical education at the University of Geneva, followed by clinical training in pathology, internal medicine, and infectious diseases in Geneva and at Massachusetts General Hospital in Boston. His scientific career began at the Whitehead Institute of MIT, and in 1990 he was recruited by the Salk Institute of San Diego to launch an AIDS research center. After seven years in the United States, he returned to Europe and eventually joined EPFL. Dr. Trono's research has evolved significantly over his career. Initially focusing on virus-host interactions, he studied pathogens like HIV and Hepatitis B virus, creating HIV-derived genetic transfer tools that are now successfully used in gene therapy. For approximately the last fifteen years, his research has centered on epigenetics, particularly exploring the impact of retroelements and their control mechanisms on development and physiology of higher organisms, including humans. His laboratory investigates how transposable elements and KRAB zinc finger proteins regulate gene expression, with important implications for understanding cancer biology and developing new diagnostic and therapeutic approaches. Analysis of his recent publications (2022-2024) reveals a strong focus on transposable elements, KRAB zinc finger proteins, and their roles in gene regulation and cancer. His work combines molecular biology, genomics, and bioinformatics approaches to understand how these ancient viral remnants have been co-opted by the host genome to regulate development and cellular functions. The research spans basic molecular mechanisms to potential clinical applications in cancer diagnosis and therapy, with some recent work also addressing SARS-CoV-2 and immune responses. Throughout his career, Professor Trono has mentored numerous PhD students, including Bojkowska Karolina, Brandão Sanches Vong Martins Filipe Amândio, Bulliard Yannick, Coluccio Andrea, Corsinotti Andrea, Coudray Alexandre, De Tribolet-Hardy Jonas Caspar, and Dorschel Iris Arianna. His laboratory has received significant funding to support research at the intersection of virology, genetics, and epigenetics, contributing to EPFL's reputation as a leading institution in life sciences research. The Trono Laboratory continues to be at the forefront of research on retroelements and their regulatory mechanisms, maintaining a vibrant research environment that bridges fundamental biological questions with potential medical applications, particularly in cancer research and precision medicine.

• Immunology
• Virology
• Inflammation
• +۵ مورد دیگر

Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.

Li Tangمشاهده پروفایل

دانشیار

• Immunoengineering
• Cancer Immunotherapy
• Immune Metabolism
• +۷ مورد دیگر

Li Tang is an Associate Professor with tenure at École polytechnique fédérale de Lausanne (EPFL), affiliated with the Institute of Bioengineering (IBI) and the Institute of Materials Science and Engineering (IMX) within the School of Engineering (STI). She leads the Laboratory of Biomaterials for Immunoengineering, focusing on developing innovative strategies at the intersection of immunology, materials science, and cancer therapy. Her work bridges fundamental research and clinical translation, with multiple ongoing clinical trials based on CAR-T cell therapies developed in her lab. B.S. in Chemistry, Peking University (2003–2007) Ph.D. in Materials Science and Engineering, University of Illinois at Urbana-Champaign (2007–2012) Postdoctoral Fellow, MIT (2013–2016) Her research lies at the forefront of immunoengineering, integrating chemical, metabolic, and mechanical approaches to modulate immune responses. Key areas include cancer immunotherapy, immune metabolism, mechano-immunology, and biomaterials. She investigates how physical and biochemical cues can reprogram T cells, overcome exhaustion, and enhance tumor targeting. Her work emphasizes multidimensional immunity-disease interactions, aiming to develop safer and more effective therapies for cancer and autoimmune diseases. The recent publications highlight a strong trend in engineering immune cells (especially CAR-T) for enhanced durability and function, using advanced biomaterials and metabolic reprogramming. There is a clear focus on overcoming challenges in solid tumors, modulating the tumor microenvironment, and translating findings into clinical applications. The use of nanoparticle delivery, single-cell analysis, and biomechanical cues are recurring themes across her work. Notable scientific awards include: Friedrich Miescher Award (2025) ERC Starting Grant (2018) MIT TR35 Innovators Under 35 (China Region, 2020) Nano Research Young Innovator Award (2018) Biomaterials Science Emerging Investigator (2019) Materials Horizons Emerging Investigator (2020) Li Tang actively mentors PhD students across multiple doctoral programs (EDBB, EDMS, EDMX) and has advised numerous graduates who have gone on to prestigious postdoctoral and faculty positions. She is involved in significant research grants, including an Innosuisse project with Novochizol SA, and her lab is supported by competitive funding. She teaches core courses such as Immunoengineering and Next-Generation Biomaterials, shaping the next generation of scientists. Her lab fosters interdisciplinary collaboration and innovation, with active projects in chemical, metabolic, and mechanical immunoengineering, as well as CAR-T cell development. She is the Principal Investigator of the Tang Lab, which includes postdoctoral fellows, PhD students, and technical staff. The lab is actively recruiting and has a strong publication and clinical translation record. Tang Lab is also involved in multiple MA/BA training projects and promotes student engagement in cutting-edge research. The lab’s discoveries are being translated into clinical trials, reflecting a strong commitment to translational science.

Urs F. Greberمشاهده پروفایل

استاد

• Virology
• Molecular Cell Biology
• Virus-Host Interactions
• +۸ مورد دیگر

Prof. Dr. Urs F. Greber is an Ordinary Professor of Molecular Cell Biology at the Department of Molecular Life Sciences, Faculty of Mathematics and Natural Sciences, University of Zurich. His research focuses on understanding how viruses interact with host cells, particularly adenoviruses and rhinoviruses that cause human respiratory diseases. He leads the Greber Lab, which investigates viral entry mechanisms, replication processes, and the cellular responses to infection. Greber's research interests span virology, molecular cell biology, and infection mechanisms. His lab explores how viruses take control over membrane and lipid functions, cytoplasmic transport processes, and cellular metabolism to support their gene expression and progeny formation. They employ system-wide profiling, molecular cell biology approaches, light microscopy, and machine learning for image analysis to map the cell state underlying viral infections of cultured and primary human cells, including lung organoids and iPSC-derived macrophages. A key focus is understanding cell-to-cell variability in infection phenotypes and the mode-of-action of antiviral compounds. The Greber Lab has published extensively on adenovirus biology, including viral entry, uncoating, nuclear import, and assembly mechanisms. Their recent work has identified broad-spectrum antiviral compounds, elucidated alternative virus entry pathways, and developed innovative imaging and AI-based approaches for quantifying virus infectivity. Their research contributes to understanding how viruses break down host defense barriers and has implications for antiviral therapy development. Greber has supervised numerous PhD and Master's students including Cornelia Bircher, Alessandro Savi, Franziska Tomas, Alfonso Gomez-Gonzalez, Anthony Petkidis, and Dominik Olszewski. His lab has received funding from the Swiss National Science Foundation, including a grant for coronavirus research during the pandemic. The lab actively collaborates with other research groups at University of Zurich, ETH Zurich, and international institutions. Current projects include exploring how viral DNA interactions contribute to infection outcome variability, investigating adenovirus egress mechanisms, and developing high-throughput screening methods for antiviral compounds.

Daniel Sageمشاهده پروفایل

مدرس

• Biomedical Imaging
• Image Processing
• Deep Learning Applications
• +۵ مورد دیگر

Daniel Sage is a Lecturer and Scientific Advisor at École polytechnique fédérale de Lausanne (EPFL) , affiliated with the Biomedical Imaging Laboratory (LIB) under the College of Engineering (STI) and School of Life Sciences (SV) . He specializes in bioimage informatics , structured-illumination microscopy , and deep learning applications for biomedical imaging. His work spans algorithm development for single-molecule localization microscopy (SMLM) , fluorescence imaging , and 3D reconstruction . His research group has developed open-source tools like FlexSIM for light inhomogeneity correction, DeepImageJ for integrating deep learning in ImageJ, and Steer'n'Detect for orientation-accurate template detection. His publications focus on correcting multiple-blinking artifacts in PALM, optimal transport metrics for SMLM evaluation, and contextual feature analysis for xenograft cell classification. He mentors PhD students and contributes to interdisciplinary education through courses such as Bioimage Informatics and Fundamentals of Image Analysis , emphasizing practical software solutions and Java programming for bioimage processing. His collaborations include institutions like Howard Hughes Medical Institute and Centre National de la Recherche Scientifique (CNRS) .

Maartje Bastingsمشاهده پروفایل

دانشیار

• Biomaterials Engineering
• DNA Nanotechnology
• Supramolecular Materials
• +۵ مورد دیگر

Maartje Bastings is an Associate Professor at the École Polytechnique Fédérale de Lausanne (EPFL) , leading the Programmable Biomaterials Laboratory (PBL) within the School of Engineering (STI) . She holds additional affiliations with the Institute of Materials (IMX) , IBI-STI (Bioengineering), and supervises doctoral programs in Biotechnology and Biological Engineering ( EDBB-GE ) and Materials Science and Engineering ( EDMX-GE ). Her research focuses on DNA-based supramolecular materials engineered to achieve dynamic reciprocity —a two-way interaction between synthetic materials and biological systems. By leveraging DNA as a programmable scaffold, she investigates structural mechanics, valency control, and geometric constraints governing self-assembly and cell communication at bio-interfaces. Key applications include immune system modulation, diagnostics , and vaccine development . Analysis of her 15 most recent publications reveals a focus on multivalent interactions for T-cell activation, spatial patterning in immune signaling, and engineered coatings for DNA origami stability. Subfields span T cell receptor engineering , nanoscale protein dynamics , stimuli-responsive biomaterials , and bio-inspired therapeutic design . PhD Students: Chen Yuduo Hendrickx Pauline Bart M. Kononenko Artem Li Shujie Lou Yameng Meyer Pitt Narita Minako Rousseau Benjamin Bila Hale Caroprese Vincenzo Comberlato Alice Kurisinkal Eva Eugene Paloja Kaltrina Rodríguez Franco Hugo José Tekin Cem Wong Siu Ho Contact: maartje.bastings@epfl.ch

Sebastian Hillerمشاهده پروفایل

استاد

• Structural Biology
• NMR Spectroscopy
• Protein Folding
• +۴ مورد دیگر

Professor Sebastian Hiller is a Full Professor at the Biozentrum of the University of Basel, Switzerland, where he leads a research group focused on structural biology and biophysics. His laboratory specializes in using nuclear magnetic resonance (NMR) spectroscopy to elucidate the structures and functions of proteins and their interactions at the atomic level. His research spans several key areas including molecular chaperones and protein folding mechanisms, outer membrane protein biogenesis in bacteria, and kinase signaling pathways. Notably, his group has made significant contributions to understanding how chaperones like trigger factor function, the mechanisms of outer membrane protein assembly through the Bam complex, and dynamic kinase interactions. Their work has direct implications for neurodegenerative diseases and antibiotic development. The Hiller lab's recent publications demonstrate a strong focus on NMR methodology development, protein folding dynamics, and structural mechanisms of antibiotic action. Their research on darobactin's mechanism of action against Gram-negative bacteria represents a significant advance in antibiotic discovery. The group frequently publishes in high-impact journals including Nature, Science, and Nature Communications. ICMRBS Founder's Medal (2018) EMBO Young Investigator (2014) ERC starting grant (2011) SNSF professorship (2010) SNSF scholarship for young researchers (2008) Professor Hiller supervises numerous PhD students and postdoctoral researchers, with many alumni having secured prestigious positions in academia and industry. His laboratory maintains strong collaborations across multiple institutions and has received significant funding through ERC grants and other competitive mechanisms. The Hiller group also operates advanced NMR facilities that serve the broader research community at the University of Basel.

• Biomedical Engineering
• Nanotechnology
• Cancer Research
• +۳ مورد دیگر

Yen-Cheng Liu is a former researcher at École polytechnique fédérale de Lausanne (EPFL), affiliated with the School of Life Sciences (BIOS) and multiple departments including LCOM and CMI. His work focuses on interdisciplinary research at the intersection of biomedical engineering, nanotechnology, and cancer biology. Key research areas include nanoplasmonic biosensors, single-cell analysis, optofluidic systems, and cancer immunology. He holds collaborations with institutions like the University of Lausanne and the Centre Hospitalier Universitaire Vaudois (CHUV). His research emphasizes real-time monitoring of cellular secretions, tumor microenvironment dynamics, and diagnostic platform development for pathogens and genetic diseases. Notable contributions include high-throughput microarray technologies for single-cell secretion profiling and optofluidic platforms for molecular diagnostics. Liu’s publications span journals like Advanced Science , Advanced Functional Materials , and Biosensors and Bioelectronics . His work integrates engineering principles with biological systems to address challenges in precision medicine and cancer therapy.

Enkelejda Mihoمشاهده پروفایل

استاد

• Digital Life Sciences
• Medical Informatics
• Artificial Intelligence in Healthcare
• +۴ مورد دیگر

Prof. Enkelejda Miho is a Professor of Digital Life Sciences at the School of Life Sciences, FHNW, leading the aiHealthLab. Her work bridges computer science/AI with life sciences, focusing on drug discovery, personalized medicine, and immunology. She holds roles as Team Leader at aiHealthLab and Group Leader at the Swiss Bioinformatics Institute. Research Interests : She applies machine learning to analyze immune repertoires, antibody engineering, and autoimmunity diagnostics. Her lab develops computational tools like the RWD-Cockpit for real-world data analysis and synthetic antibody-antigen models (Absolut!) to advance biotherapeutics. Her work on dengue immunity and monoclonal gammopathies highlights translational applications. Key Projects : The aiHealthLab focuses on AI-driven diagnostics and therapeutics. Her contributions include AI frameworks for antibody specificity prediction, age-related immune repertoire changes, and large-scale network analysis of antibody repertoires. Labs/Teams : Leads aiHealthLab and collaborates with the Swiss Bioinformatics Institute, integrating computational and experimental immunology.

Freddy Radtkeمشاهده پروفایل

استاد

• Molecular Biology
• Cellular Biology
• Cancer Research
• +۹ مورد دیگر

Freddy Radtke is a Full Professor at the School of Life Sciences at École polytechnique fédérale de Lausanne (EPFL), where he leads the Radtke Lab (UPRAD) within the Swiss Institute for Experimental Cancer Research (ISREC). He holds multiple affiliations across EPFL, including in the SSV-ENS and EDMS-ENS programs, reflecting his broad engagement in teaching and doctoral education in life sciences. His research is centered on the molecular mechanisms of stem cell maintenance and differentiation, particularly through the Notch signaling pathway. His work spans several self-renewing systems: the hematopoietic system, skin, and gut. Key findings include the identification of Delta-like 4 as the essential Notch1 ligand for T cell commitment, the tumor suppressor role of Notch1 in skin, and its critical function as a gatekeeper of intestinal progenitor cells by repressing CDK inhibitors. These discoveries have significant implications for understanding cancer development and regenerative processes. The recent publications highlight a consistent focus on Notch signaling across diverse biological contexts—hematopoiesis, skin development, intestinal regeneration, and stem cell systems biology. The keywords and subfields reflect deep mechanistic investigations into cell fate decisions, signal transduction, and tissue homeostasis, with strong translational relevance to cancer and inflammatory diseases. Freddy Radtke has mentored numerous Ph.D. students and is actively involved in teaching courses such as Stem Cells and Organoids and Scientific Project Design in Translational Oncology . His lab conducts research supported by external funding, and he collaborates across disciplines to integrate systems biology with stem cell research. The lab includes scientists, doctoral assistants, technicians, and administrative staff, indicating a vibrant and multidisciplinary research team.

• Cellular Immunology
• T Cell Biology
• Immunological Memory
• +۷ مورد دیگر

Federica Sallusto is a Full Professor in Medical Immunology at ETH Zurich and Università della Svizzera italiana (USI), and a Group Leader in the Cellular Immunology department at the Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland. She leads a prominent research group focused on human T cell biology, immunological memory, and immune responses in infection and autoimmunity. Doctor in Biology, University of Rome, 1988 Postdoctoral work: Istituto Superiore di Sanità, Rome; Basel Institute for Immunology Group Leader, IRB, since 2000 Full Professor, ETH Zurich and USI, since 2017 Her research centers on the heterogeneity and function of human CD4+ T cell subsets, particularly Th17 and T follicular helper cells, and their roles in protective immunity and inflammatory diseases. She investigates immune responses to pathogens such as Mycobacterium tuberculosis, influenza, SARS-CoV-2, and HIV, using cutting-edge techniques in cellular immunology and systems immunology. Her work integrates human immunology with translational applications in vaccinology and autoimmune disorders. The recent publications reflect a strong focus on human immune responses to infectious agents, mechanisms of T and B cell immunity, and the intersection of immunology with neurology and autoimmunity. Key themes include antigen-specific T cell activation, antibody cross-reactivity, regulation of inflammatory pathways, and the impact of vaccines and infections on immune memory and disease outcomes. Pharmacia Allergy Research Foundation Prize Behring Lecture Member, German Academy of Sciences Leopoldina (2009) Member, EMBO (2011) International Member, U.S. National Academy of Sciences (2022) Doctor honoris causa, University of Fribourg (2022) Federica Sallusto has mentored numerous students and postdoctoral researchers, many of whom are co-authors on her high-impact publications. Her group has received significant funding from the European Research Council (ERC), Marie Curie Actions, and the Swiss National Science Foundation (SNSF), where she served on the National Research Council from 2018 to 2024. She has held leadership roles including President of the Swiss Society for Allergology and Immunology (2013–2015) and President of the European Federation of Immunological Societies (2022–2024). Her laboratory is embedded within the IRB, a leading biomedical research institute affiliated with USI, and collaborates extensively with clinical and research teams across Europe. The group is part of broader scientific networks in antibody discovery, infectious disease immunology, and neuroimmunology.

Monticelli Silviaمشاهده پروفایل

استاد پژوهشی

• Molecular Immunology
• T lymphocyte biology
• Mast cell biology
• +۴ مورد دیگر

Silvia Monticelli is a Group Leader in Molecular Immunology at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland. She earned her Ph.D. from the University of Milan and has held research positions at San Raffaele Scientific Institute, King’s College London, and Harvard Medical School. Her research focuses on transcriptional and post-transcriptional regulation of immune responses, particularly in T lymphocytes and mast cells. Education: Ph.D. – University of Milan, Italy Postdoctoral training – San Raffaele Scientific Institute, Milan Research training – Randall Institute, King’s College London Research training – Center for Blood Research, Harvard Medical School Research Interests: Silvia Monticelli’s lab investigates the molecular mechanisms that control gene expression in immune cells. Her work spans epigenetic regulation , microRNA function , transcription factor networks , and RNA methylation in T cells and mast cells. A central theme is understanding how these mechanisms shape immune cell identity and function in health and disease. Publication Trends: Her recent publications (2020–2024) reflect a strong emphasis on RNA biology , epigenetic control , and immune regulation . She has contributed to high-impact journals such as Nature , Nature Immunology , and Science Advances , with work ranging from microRNA-mediated control of T cell activation to epigenetic regulation in mast cells and cancer immunity. Scientific Recognition: While no formal awards are listed, her work has been highlighted by editorial commentary and co-corresponding authorships in high-impact journals, indicating recognition within the immunology community. Labs & Affiliations: She leads a research group at the IRB in Bellinzona, focusing on immune cell regulation at the molecular level. Her lab is part of a broader European research network and collaborates with institutions like Harvard and the University of Milan.

Xiao-Hua Qinمشاهده پروفایل

استادیار

• Biomaterials Engineering
• Regenerative Medicine
• Tissue Engineering
• +۵ مورد دیگر

Prof. Xiao-Hua Qin is an Assistant Professor in the Department of Health Sciences and Technology at ETH Zürich, leading the Biomaterials Engineering research team and co-leading the Laboratory for Bone Biomechanics. He specializes in creating biomaterials for tissue biomanufacturing and regenerative medicine, with a focus on miniaturized in vitro bone models for disease modeling and drug discovery. His work has been recognized by prestigious grants such as the ERC Starting Grant and SNSF NRP 79, and he co-leads editorial roles for Biomedical Materials . He teaches courses on engineering with living materials and multiscale bone biomechanics. His research emphasizes constructing 3D microenvironments to study bone physiology/pathology, with recent breakthroughs in hydrogel-based systems for cell network formation and organoid-on-chip tools. He has pioneered techniques like two-photon subtractive biofabrication and volumetric bioprinting. Qin's honors include Young Academy of Europe membership and multiple awards for innovative biomaterials and poster presentations. He mentors 6 PhD students and collaborates across disciplines, aiming to replace animal experiments with human organoid models (3Rs principle). His lab's innovations span biodegradable hydrogels, photoresponsive materials, and microscale 3D printing technologies.

Maud Friedenمشاهده پروفایل

دانشیار

• Cell Physiology
• Muscle Regeneration
• Stem Cell Biology
• +۳ مورد دیگر

Maud Frieden is an Associate Professor at the Department of Cell Physiology and Metabolism, University of Geneva. Her lab focuses on skeletal muscle regeneration mechanisms using human stem cell models. Key research areas include muscle satellite cell activation, calcium signaling pathways, and the molecular basis of muscle diseases like myopathies. Research Interests: Frieden’s work investigates how muscle stem cells (satellite cells) repair damaged muscle tissue. Recent projects explore store-operated calcium entry (SOCE) pathways in muscle differentiation and the role of mitochondrial dysfunction in muscle atrophy. Advanced in vitro models are used to study human myotube maturation and disease mechanisms. Lab Team: Current members include PhD students Jessica Brunetti and Julie Perroud, postdoc Axel Tollance, and lab technician Olivier Dupont. The team collaborates with experts in proteomics (e.g., Eckhardt et al., 2023) and cardiac physiology (Rusiecka et al., 2023). Publications: Recent work highlights ER stress-IRE1 interactions in muscle regeneration (Carreras Sureda et al., 2023) and TRPC channel roles in myogenesis (Antigny et al., 2013-2022). Over 30 peer-reviewed articles span muscle biology, calcium signaling, and stem cell research.

Vladimir Katanaevمشاهده پروفایل

استاد

• Wnt Signaling Pathway
• Cancer Biology
• GPCR Signaling Mechanisms
• +۳ مورد دیگر

Prof. Vladimir Katanaev is a Full Professor at the University of Geneva's Faculty of Medicine, affiliated with the Department of Cellular Physiology and Metabolism and the Centre for Translational Research in Onco-haematology. His research focuses on oncogenic signaling pathways, particularly the Wnt signaling pathway's role in cancer and developmental biology. He combines fundamental and translational research to develop anti-cancer therapies, including Wnt inhibitors and novel drug candidates. His work also extends to G protein-coupled receptor (GPCR) signaling mechanisms and biomimetic nanocoatings inspired by biological structures. Educated at Krasnoyarsk and Moscow State Universities, he completed his PhD at the University of Fribourg (Switzerland) and a postdoc at Columbia University (USA). Key roles include leading a research group at the University of Konstanz (2005–2011) and joining the University of Lausanne as an associate professor before moving to UNIGE in 2018. His lab investigates Wnt pathway inhibitors, GNAO1-related encephalopathies, and synthetic applications of biological nanocoatings. Research highlights include identifying natural product-based anticancer agents, developing personalized therapies for genetic disorders, and exploring light-interacting nanomaterials. Collaborators include postdoctoral fellows and scientific collaborators like Jana Valnohova and Gonzalo Solis. His work bridges basic science and clinical translation, aiming to advance oncology and neurology treatments.